Phase 0 open, single-center clinical study to evaluate the safety, tolerability and anti-tumor effects of BM201 injection combined with radiotherapy in patients with advanced malignant solid tumors

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: 00f48ad7bb8826708c3dc2eaeda83706e54667d1
First added on: Apr 08, 2025